Privia Health Group Aktie News

ARLINGTON, Va., April 09, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it plans to release financial results for its first quarter ended March 31, 2024 before market open on Thursday, May 9, 2024.

Privia Health Group, Inc. (NASDAQ:PRVA) Q4 2023 Earnings Conference Call February 27, 2024 8:00 AM ET

Achieved All 2023 Operating and Financial Guidance Metrics Implemented Providers +19.4% compared to Year-End 2022 Introduces Full-Year 2024 Guidance Proactive Steps to Limit Downside Risk Arrangements in Current Medicare Advantage Environment for More Favorable Contract Structures and Margin Contribution ARLINGTON, Va., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) ...

ARLINGTON, Va., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced that Edward C. Fargis has been named Executive Vice President, General Counsel and Corporate Secretary, effective today. Mr. Fargis will serve as the Company's chief legal officer, working with Privia executive leadership to support the Company's long-term direction and growth.

ARLINGTON, Va., Jan. 23, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it plans to release financial results for its fourth quarter and full year ended December 31, 2023 before market open on Tuesday, February 27, 2024.

ARLINGTON, Va., Dec. 12, 2023 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that its management team plans to present at the 42nd Annual J.P.

NASHVILLE, Tenn.--(BUSINESS WIRE)--Calm Waters AI, a fully autonomous, artificial intelligence Evaluation & Management (E/M) coding application for providers, has finalized an agreement with Privia Health™, which supports provider groups in delivering more efficient and effective patient care. Under the agreement, provider groups affiliated with Privia can implement and use Calm Waters AI at a ...

Privia Health Group, Inc (NASDAQ:PRVA ) Q3 2023 Earnings Call Transcript November 3, 2023 9:00 AM ET Company Participants Robert Borchert - SVP, Investor & Corporate Communications Parth Mehrotra - President and CEO David Mountcastle - CFO Conference Call Participants Joshua Raskin - Nephron Research Elizabeth Anderson - Evercore ISI Jailendra Singh - Truist Securities Richard Close - Canaccord...